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TIME-INVARIANT  TENSILE  NECKING  OF  BLOOD 
ON  AN  ELECTROWETTING  DIGITAL  MICROFLUIDIC  PLATFORM 
 
by  Curtis  Young 
 
Recent  developments  in  electrowetting-on-dielectric  (EWOD)  technology  have 
expanded  the  possibilities  for  testing  methods  and  investigation  of  blood.  This  work 
evaluated  the  development  of  necking  geometry  of  whole  blood  and  red  blood  cell  (RBC) 
suspensions  on  a  digital  microfluidic  (DMF)  platform.  This  was  achieved  by  applying 
tension  to  liquid  droplet  specimens  on  an  EWOD-based  device  using  applied 
electrowetting  forces,  thereby  inducing  necking.  The  deformation  of  5  μL  fluid 
specimens  was  recorded  using  neck  radius  and  minimum  neck  width  as  two  characteristic 
geometric  parameters.  Tensile  tests  were  performed  on  phosphate-buffered  saline  (PBS), 
whole  blood  diluted  in  PBS,  and  RBCs  suspended  in  PBS  at  hematocrit  values  of  10%. 
Although  rheological  measurements  suggested  higher  stiffness  of  RBC  suspensions  when 
treated  with  neuraminidase,  necking  profiles  were  indistinguishable  from  those  of 
untreated  RBC  suspensions.  When  tested  at  two  different  dilutions,  whole  blood  diluted 
1:20  and  1:10  in  PBS  exhibited  distinct  necking  profiles.  The  necking  development  was 
observed  to  be  time-invariant  and  insensitive  to  the  large  variability  otherwise  observed 
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1.  INTRODUCTION 
1.1  Background 
Blood  plays  many  vital  roles  within  the  human  body.  It  comprises  several  major 
components:  red  blood  cells  (RBCs)  transport  oxygen  and  carbon  dioxide  between  the 
lungs  and  tissue,  white  blood  cells  (WBCs)  fight  infection  and  regulate  immune  function, 
platelets  help  form  clots,  and  plasma  contains  clotting  proteins  and  nutrients  [1],  [2] . 
Electrowetting-based  digital  microfluidic  (DMF)  devices  provide  a  platform  for  novel 
methods  of  investigating  blood  which  can  offer  advantages  over  current  analysis 
techniques.  Electrowetting-based  DMF  platforms  have  seen  significant  recent 
development  especially  as  “lab-on-a-chip”  devices  that  create,  combine,  move,  and  split 
droplets  of  liquid  [3] .  Such  platforms  operate  based  on  the  principles  of  electrowetting, 
which  involves  the  modification  of  the  contact  of  liquid  on  a  surface  using  an  applied 
electric  field  [4] .  Electrowetting  was  first  harnessed  when  Lippmann  used 
externally-added  electrostatic  charge  to  alter  capillary  forces  at  the  interface  of  polarized 
mercury-electrolyte  to  construct  an  electrometer  [5] ,  and  modern  applications  of 
electrowetting  include  adjustable  liquid  lenses,  electronics  displays,  and  droplet 
manipulation  platforms  [3],  [6],  [7] . 
The  contact  of  a  fluid  on  a  surface  can  be  described  by  the  wetting  angle,  or  the 
contact  angle  between  the  surface  and  the  profile  of  the  fluid  droplet.  A  fluid-surface 
contact  with  a  wetting  angle  greater  than  90°  is  described  as  hydrophobic  and  a  contact 
with  a  wetting  angle  less  than  90°  is  described  as  hydrophilic  [8] .  Electrowetting-on 
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dielectric  (EWOD)  devices  utilize  an  applied  voltage  through  a  conductive  surface  with 
an  additional  layer  acting  as  a  dielectric  between  the  fluid  and  conductive  layer  [9] .  When 
an  electrowetting  voltage  is  applied  over  the  droplet  to  the  conductive  layer,  a  parallel 
plate  capacitor  is  formed  at  the  interface,  ultimately  reducing  the  wetting  angle  of  the 
fluid.  As  such,  an  electrowetting  voltage  reduces  the  hydrophobicity  of  a  fluid-surface 
contact. 
Fluid  droplet  manipulation  can  be  achieved  by  harnessing  this  behavior  using  a 
surface  with  multiple  independent,  adjacent  electrodes.  When  a  droplet  is  positioned  over 
an  electrode,  applying  a  voltage  over  an  adjacent  electrode  reduces  the  hydrophobicity  of 
the  fluid  locally  over  the  actuated  electrode.  If  the  resulting  driving  force  within  the 
droplet  overcomes  the  shear  and  viscous  drag  forces,  the  droplet  will  move  onto  the 
actuated  electrode.  Using  this  principle  of  droplet  actuation,  droplet  operations  such  as 
mobilization,  splitting,  and  mixing  are  made  possible.  Droplet  actuation  on  an  open 
surface  can  prove  to  be  demanding,  requiring  excessively  high  voltages  and  performing 
inconsistently.  Accordingly,  many  modern  EWOD  droplet  manipulation  platforms  use 
designs  which  reduce  the  actuation  requirements  [10] .  A  hydrophobic  layer  is  often 
applied  over  the  insulating  dielectric  layer,  reducing  the  drag  on  the  droplet.  In  addition, 
two-plate  designs  are  commonly  used,  employing  a  top  plate  with  a  conductive  layer  and 
hydrophobic  coating.  
Key  advantages  that  EWOD  platforms  offer  over  mechanical  testing  systems  for 
biofluids  are  reduced  reagent  volume  and  improved  mixing  consistency.  Actuation  with 
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electrical  signals  over  patterned  electrodes  on  the  platform  can  create  and  manipulate 
precise,  microliter-scale  droplets  and  mix  reagents  into  far  less  heterogeneous 
combinations  than  conventional  methods  [11] .  In  addition,  EWOD  platforms  offer 
simplicity  relative  to  other  microfluidic  systems,  as  they  use  only  electrical  signals  on  a 
patterned  surface  rather  than  pumps,  valves,  or  other  mechanical  components.  This 
allows  for  lower-cost  fabrication,  greater  portability,  and  more  convenient  automation  of 
operations  [3],  [12],  [13] . 
1.2  Hypothesis 
The  hypothesis  of  this  work  is  that  blood  and  RBC  suspensions  will  have  a 
characteristic  curve  based  on  necking  geometry  which  is  robust  against  variability  in  the 
temporal  development  during  on-chip  testing.  The  rationale  for  this  hypothesis  is  that  the 
temporal  response  of  liquids  to  electrowetting  forces  can  be  highly  dependent  on 
device-specific  variability  in  features  such  as  gap  spacing  and  hydrophobic  coating 
uniformity,  yet  ultimately  a  liquid  will  still  tend  toward  a  lowest-energy  equilibrium 
shape. 
1.3  Significance 
An  increased  understanding  of  blood  and  its  components  leads  to  the  development  of 
treatments  for  diseases.  For  instance,  anemia  is  a  dangerous  condition  characterized  by  a 
lack  of  functioning  red  blood  cells.  Anemia  is  correlated  with  severe  complications  in 
cardiovascular  disease  such  as  stroke  and  venous  thrombosis,  but  the  mechanisms  behind 
this  effect  are  not  well  understood  [1],  [14],  [15] .  A  method  of  investigation  on  a  digital 
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microfluidic  platform  presents  options  for  point-of-care  testing  for  anemia.  This  would 
expand  the  capabilities  of  current  assays  as  well  as  allow  new  assays  to  be  devised  based 
on  the  digital  microfluidic  platform.  While  the  use  of  biofluids  on  a  digital  microfluidic 
platform  has  been  investigated,  a  time-invariant  method  of  investigating  the  geometry  of 
liquid  specimens  has  not  been  explored.  This  can  mitigate  issues  of  variability  between 
addressable  sites  on  a  digital  microfluidic  device.  While  the  role  of  RBC  surface  charge 
is  well-studied  with  regards  to  its  effect  on  agglutinability  [16]  and  its  consequent 
influence  on  blood  rheometry,  investigation  on  a  DMF  device  reveals  the  behavior  of 
charged  and  uncharged  cells  during  flow  within  an  electric  field.  The  use  of  a  DMF 
platform  means  RBC  suspensions  can  be  compared  with  high  spatial  and  temporal 
resolution,  revealing  previously  undiscovered  differences  in  their  behavior. 
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2.  RELATED  WORK 
2.1  Biofluids  in  Microfluidics 
To  combine  reagents  on  a  digital  microfluidic  platform,  droplet  mixing  operations  are 
necessary.  Paik  et  al.  determined  that  in  linear  array  mixing,  aspect  ratio  of  droplet 
specimens  plays  an  important  role  [17] .  In  aspect  ratios  ranging  from  0.2  to  0.66,  an 
aspect  ratio  of  0.4  was  found  to  produce  optimal  mixing  results,  and  0.2  the  worst  mixing 
results.  Droplet  samples  ranged  from  2350  nL  to  800  nL,  with  gap  heights  ranging  from 
600  μm  to  1  mm,  and  mixing  times  ranging  from  1.7  s  to  14.9  s.  Flow  reversibility  effects 
have  been  shown  to  hinder  mixing,  and  methods  to  reduce  this  were  explored  using  larger 
electrode  arrays  with  the  aspect  ratio  of  0.4.  Using  a  2  x  4  electrode  array  with  a 
droplet-pivot  mixing  method  resulted  in  a  mixing  time  of  2.9  s  for  two  1.4  μL  droplets. 
The  EWOD  device  used  actuated  droplets  in  silicone  oil  at  50  V  with  a  frequency  of  16 
Hz.  Mixing  results  were  obtained  by  combining  a  fluorescent  droplet  with  a  stationary, 
non-fluorescent  droplet  and  subsequent  image  processing. 
While  radial  droplet  stressing  through  electrowetting  has  been  regular  practice, 
longitudinal  droplet  stressing  has  been  uncommon.  Much  of  the  established  literature 
concerning  this  mode  of  droplet  stressing  and  deformation  has  been  related  to  droplet 
cutting.  Cho  et  al.  achieved  droplet  cutting  by  deforming  a  droplet  longitudinally  over  a 
line  of  three  electrodes  [10] .  In  this  configuration,  the  two  outer  electrodes  were  activated 
while  the  center  electrode  is  grounded.  This  caused  the  contact  angle  of  the  droplet  at 
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each  end  to  decrease  as  the  local  radii  of  curvature  increase.  As  the  droplet  volume  must 
stay  constant,  the  meniscus  over  the  center  electrode  pinched,  initiating  the  cut. 
2.2  Electrowetting  of  Biofluids 
Barbulovic-Nad  et  al.  demonstrated  the  use  of  an  electrowetting-based  device  for 
biofluids,  specifically  in  implementing  cell-based  assays  [18] .  Each  EWOD  platform 
used  chromium/gold  electrodes,  a  Parylene-C  dielectric  layer  of  2  µm,  and  a  Teflon-AF 
hydrophobic  layer  of  50  nm.  Using  AC  voltages  of  up  to  140  V  and  a  two-plate  assembly, 
Jurkat  T-cells  were  combined  with  a  reagent  in  150  nL  droplets.  There  were  no  observed 
effects  on  cell  biochemistry  due  to  the  actuation,  suggesting  DMF  devices  have  potential 
in  similar  applications.  
Li  et  al.  explored  electrowetting  on  a  blood  droplet  using  an  open  configuration 
device  and  wire  electrode  with  rabbit’s  blood  [19] .  The  blood  droplet’s  change  in  contact 
angle  was  measured  in  response  to  the  applied  electrowetting  force.  Over  an  applied 
voltage  range  from  0  V  to  60  V,  the  blood  droplet  changed  wetting  angle  from  106°  to 
85.9°.  Additionally,  an  EWOD  platform  was  used  by  Mais  et  al.  to  extract  analytes  in 
order  to  quantify  amino  acids  in  dried  blood  spot  samples,  actuating  extraction  solvent 
and  extracted  amino  acid  solution  on  a  two-plate  DMF  device  [20]  and  Ng  et  al.  actuated 
dilute  whole  blood  on  a  digital  microfluidic  platform  for  remote  serological 
immunoassays  [21] . 
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2.3  Rheology 
Blood  is  a  non-Newtonian  and  viscoelastic  substance.  The  rheology  of  blood  is 
influenced  by  plasma  viscosity  as  well  as  RBC  behavior  [22],  [23] .  Under  low-flow 
conditions,  RBCs  form  aggregates,  which  are  highly  influential  to  blood  flow  in 
low-shear  regions.  Initially,  linear  stacks  of  cells  formed,  a  phenomenon  known  as 
rouleaux  formation.  The  rouleaux  stacks  then  interact  to  form  larger,  three-dimensional 
structures  [24] .  The  size  of  these  aggregates  is  inversely  proportional  to  the  shear  forces, 
as  they  are  dispersed  with  increasing  shear  forces.  The  cell  deformability  and  orientation 
of  RBCs  are  the  primary  cellular  factors  influencing  blood  fluidity  at  high  shear  rates 
[25]–[27] .  Due  to  the  contribution  of  RBC  behavior  to  blood  rheology,  blood  viscosity 
increases  exponentially  with  hematocrit  [28] .  
2.3.1  Microfluidic  Rheometry 
Microfluidics  present  opportunities  to  mitigate  issues  inherent  to  macroscale  shear 
rheometry,  including  low-viscosity  fluids,  interfacial  artifact  effects,  and  small  sample 
volumes  [29] .  Microfluidic  rheometry  devices  can  measure  shear  viscosity  or  extensional 
properties  of  a  fluid.  Examples  of  microfluidic  shear  rheometry  include  methods  based  on 
pressure  sensing,  flow  rate  sensing,  surface  tension,  and  diffusion  in  a  microchannel.  The 
extensional  properties  of  a  fluid  can  be  investigated  using  methods  such  as  stagnation 
point  flow  or  contraction  geometries  [29],  [30] .  Each  method  has  a  range  of  effective 
operation  for  both  shear  rate  and  viscosity.  General  challenges  faced  by  microfluidic 
rheometry  methods  include  cleanability  and  biofouling  fluids,  increasing  an  inherently 
7 
low  throughput,  integrating  optical  devices,  and  operating  with  a  broad  range  of  shear 
rates  [31] . 
Banpurkar  et  al.  explored  the  use  of  electrowetting  as  a  method  for  performing 
rheometry  experiments  on  a  microfluidic  chip  [32] .  This  was  done  by  measuring  the 
electrowetting  response  of  gelatin  solutions.  An  open  electrowetting  platform  was 
fabricated  by  patterning  an  indium  tin  oxide  (ITO)-coated  glass  slide  and  coating  with 
Teflon  AF  1600.  Aqueous  droplets  were  dispensed  on  the  electrowetting  platform,  and  a 
platinum  wire  was  inserted  into  the  droplet  to  form  a  circuit.  AC  current  ranging  from  0 
to  110  V rms   was  applied  to  the  droplets  at  10  kHz.  As  the  droplets  entered  the  gel  state,  the 
change  in  contact  angle  became  less  pronounced.  A  model  taking  into  account  interfacial 
energies,  electrostatic  energy,  and  deformation  energy  was  developed  and  fitted  to 
experimental  data,  ultimately  obtaining  the  elastic  modulus.  The  results  were  compared 
to  “macro”  oscillatory  rheometry,  specifically  the  measured  storage  modulus.  The 
electrowetting  rheometry  elastic  modulus  matched  well  with  the  macro  rheometry  storage 
modulus,  but  it  was  noted  that  the  strain  field  was  significantly  less  uniform  in  the 
electrowetting  experiment. 
2.3.2  Neuraminidase  Treatment  for  RBC  Surface  Charge  Removal 
Neuraminidase  is  an  enzyme  that  removes  sialic  acid  on  the  surface  of  RBCs, 
reducing  negative  surface  charge  and  increasing  the  cells’  tendency  to  aggregate.  This 
affects  the  rheology  of  RBCs  [16] .  Jan  and  Chien  studied  the  role  of  RBC  surface  charge 
in  electrophoretic  mobility  and  cell  agglutinability,  specifically  the  effects  of  different 
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dextrans  on  neuraminidase-treated  RBCs  [33] .  When  suspended  in  saline,  RBCs  were  not 
observed  to  have  any  increased  aggregation.  However,  when  various  dextrans  (Dextran 
20,  Dextran  40,  Dextran  80)  were  added,  a  dramatic  difference  in  aggregation  was 
observed  between  treated  and  untreated  cells.  Wen  et  al.  further  examined  the  influence 
of  neuraminidase  treatment  on  the  rheology  of  RBCs  using  rabbit  cells  suspended  in 
plasma  at  H=35%  [34] .  Cell  aggregate  sizes  were  measured  for  a  range  of  neuraminidase 
doses  (0  mU/mL  up  to  100  mU/mL)  as  well  as  a  range  of  incubation  times  (30  min  to  90 
min)  at  a  dosage  of  75  mU/mL.  The  viscosity  was  also  determined  for  RBCs  over  the 
previous  range  of  neuraminidase  dosages  using  cone-plate  rheometry.  The  viscosity  at 
both  low  shear  rate  (10  s -1 )  and  high  shear  rate  (150  s -1 )  was  shown  to  increase  with 
neuraminidase  dosage. 
2.3.3  Extensional  Flow  Rheometry 
The  use  of  an  applied  tensile  force  on  a  viscoelastic  fluid  has  been  explored  for  use  as 
a  rheometry  method.  Extensional  rheometry  can  dramatically  simplify  experimental 
methods  relative  to  shear  rheometry.  However,  any  filament-stretching  extensional 
method  will  cause  a  non-constant  stress  in  the  sample  in  response  to  a  constant  applied 
force  due  to  decreasing  cross-sectional  area.  Matta  and  Tytus  investigated  the  rapid 
stretching  of  a  liquid  filament  under  constant  tensile  force  [35] .  This  was  done  by 
inserting  a  liquid  specimen  between  the  ends  of  two  cylinders  oriented  vertically.  The 
lower  cylinder  was  dropped,  stretching  the  liquid.  The  elongational  viscosity  was 
determined  for  viscous  Newtonian  liquids  and  viscoelastic  liquids  by  imaging  the  liquid 
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stretching  and  calculating  the  stress  and  deformation  rate.  This  liquid  stretching  method 
proved  suitable  for  measuring  the  extensional  viscosity  of  Newtonian  liquids.  For 
viscoelastic  liquids,  the  ratio  of  stress  and  deformation  rate  increased  at  a  rate  dependent 
on  the  rate  of  applied  stress.  
Szabo  et  al.  later  subsequently  devised  a  method  using  this  falling  cylinder  technique 
to  characterize  the  extensibility  of  a  polymer  solution  rather  than  directly  determine  the 
extensional  viscosity  [36] .  In  this  work,  the  viscoelastic  properties  of  the  polymer 
solution  were  explored  by  applying  large  strains  and  strain  rates  to  the  liquid.  Two 
kinematic  descriptions,  one  using  an  axially-uniform  filament  approximation  and  another 
using  a  quasi-two-dimensional  Lagrangian  model  of  the  elongating  filament,  were  used 
with  a  numerical  model  to  obtain  an  estimate  of  the  maximum  extensibility  of  the 
polymeric  chains  in  the  solution.  Additionally,  an  expression  was  developed  to  extract  the 
extensibility  estimate  from  geometry  parameters  of  the  filament,  which  could  easily  be 
measured  visually.  Specifically,  an  extensibility  parameter  was  found  to  depend  directly 
on  the  ratio  of  the  nominal  liquid  radius  and  a  specific  filament  radius.  
Sousa  et  al.  investigated  the  behavior  of  human  blood  in  uniaxial  extensional  flow 
[37] .  In  this  work,  the  filament  thinning  of  blood  specimens  was  observed  by  inducing 
capillary  breakup  of  blood  specimens.  Similar  to  the  cylinder  method,  the  capillary 
breakup  was  observed  by  placing  whole  blood  between  the  ends  of  two  rods,  which  were 
then  moved  apart  at  a  constant  velocity  of  10  μm/s.  The  time  evolution  of  the  minimum 
filament  diameter  for  whole  blood  was  measured  using  high-speed  imaging  techniques. 
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From  this,  the  blood  relaxation  time  was  calculated  using  the  exponential  decay  of  the 
filament  diameter  in  the  elasto-capillary  regime  [38] .  For  hematocrit  levels  ranging  from 
38.7%  and  46.3%,  it  was  shown  the  variation  of  extensional  relaxation  time  was  minimal. 
The  average  extensional  relaxation  time  in  air  was  114  μs  ±  30  μs  and  259  μs  ±  47  μs  in 
silicone  oil.  Additionally,  increasing  the  RBC  concentration  was  shown  to  increase  the 
bulk  viscosity,  which  slowed  filament  thinning  and  decreased  the  necking  rate  of  the 
specimen.  In  RBCs  suspended  in  phosphate-buffered  saline  (PBS),  no  significant  cell 
aggregation  was  observed,  but  RBCs  suspended  in  plasma  revealed  a  small  level  of 
aggregation.  Particularly  near  the  breakup  the  filament,  a  highly  heterogeneous 
distribution  of  cells  was  observed  in  tested  specimens,  with  some  distinct  aggregates.  
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3.  THEORY 
3.1  Electrowetting  Forces 
The  driving  forces  on  the  droplet  can  be  estimated  using  the  Young-Lippmann 
equation,  which  relates  contact  angle  and  applied  voltage  on  a  droplet  [39],  [40] .  The 
Young-Lippmann  equation  can  be  obtained  in  a  form  which  describes  the  relationship 
between  the  static  contact  angle  θ ,  the  non-voltage  contact  angle  θ 0 ,  each  layer’s 
permittivity  ε 1   and  ε 2 ,  each  layer’s  thickness  d 1   and  d 2 ,  the  applied  voltage  V ,  the  surface 
tension  of  the  medium  γ ,  and  the  permittivity  of  a  vacuum  ε 0   [5],  [41],  [42] .  
 
(1) 
In  the  case  of  dielectric  and  hydrophobic  layers  as  part  of  the  EWOD  platform,  the 
capacitance  per  unit  area  can  be  calculated  in  terms  of  each  layer’s  relative  permittivity  ε i  
and  each  layer’s  thickness  h i ,  and  the  permittivity  of  a  vacuum  ε 0 .  
 
(2) 
In  this  model,  the  droplet  movement  is  driven  by  capillary  force  on  the  triple  line  of 
contact  line  between  the  droplet,  substrate,  and  medium.  The  capillary  line  force  density 
f w   is  given  by  the  contact  angle  θ  and  surface  tension  γ  [42] . 
 (3) 
This  can  be  integrated  over  the  contour  line  L  to  obtain  the  driving  capillary  force  F  on 
the  droplet  in  a  direction  of  unit  vector  ,  where    is  the  unit  normal  vector  to  the 




Integrating  over  the  contact  line  results  in  the  capillary  driving  force  on  the  droplet. 
 
(5) 
This  approach  has  several  shortcomings.  In  DMF  applications,  driving  forces  are  largely 
due  to  electrostatic  forces  rather  than  a  change  in  the  contact  angle.  Furthermore,  the 
thermodynamic  approach  does  not  consider  liquid  dielectrophoretic  forces  [39] .  
3.2  Dielectrophoretic  Forces 
Liquid  dielectrophoretic  forces  are  caused  by  an  electric  field  gradient  within  the 
droplet  in  a  two-plate  DMF  chip.  This  occurs  due  to  the  voltage  difference  from  the 
electrode  to  the  top  plate,  with  the  droplet  between  the  two  [39],  [43] .  Using  an 
electromechanical  model  of  the  DMF  platform,  the  capacitively  stored  energy  in  the 
system  can  be  determined  as  a  function  of  position  and  frequency.  Equation  (6)  gives  the 
stored  energy  for  liquid  being  actuated  within  a  filler  substance,  where  E  is  the  stored 
energy,  f  is  the  frequency  of  the  electrical  signal,  x  is  a  spatial  dimension  on  plane  of  the 
chip,  L el   is  the  electrode  length,  V liquid   and  V filler   are  the  voltage  values  for  liquid  and  filler 
respectively,  and  𝜀 liquid   and  𝜀 filler   are  the  permittivity  values  for  the  liquid  and  filler, 




The  force  on  the  droplet  is  the  derivative  of  the  energy  with  respect  to  the  droplet  position 





A  critical  frequency  can  be  determined  based  on  the  device’s  geometry  and f c
materials.  When  operating  at  or  under  this  critical  frequency,  the  dominant  cause  of 
driving  forces  on  the  droplet  is  accumulated  charge  at  the  triple  line.  When  above  ,  the f c
dominant  cause  of  driving  forces  on  the  droplet  is  the  electric  field  gradient  inducing 
dielectrophoretic  forces  pulling  the  droplet  towards  the  electrode  [39] .  Because  of  this, 
the  thermodynamic  electrowetting  model  applies  while  below  ,  and  the f c
dielectrophoretic  model  applies  while  above  .  The  critical  frequency  is  given  as  a f c f c
function  of  the  capacitance  and  conductance  of  elements  of  the  system  where  g L   is  the 
liquid  conductance,  C pt   is  capacitance  of  the  lower  plate  hydrophobic  and  dielectric  layer, 





4.  METHODOLOGY 
Tensile  tests  were  performed  on  an  EWOD-based  DMF  platform  (DB3-120,  Sci-Bots 
Inc.,  Kitchener,  Ontario,  Canada).  Experiments  were  performed  on  PBS,  whole  blood 
diluted  in  PBS,  and  RBCs  suspended  in  PBS  at  H=10%.  All  experiments  were  performed 
on  DMF  chips  (Sci-Bots).  
4.1  Experimental  Assembly 
The  DropBot  DB3-120  system  [45]  was  used  as  the  primary  DMF  platform  for  this 
experiment.  The  system  includes  a  DropBot  DB3-120  instrument,  a  12  V  power  supply,  a 
test  board,  USB  A/B  cable,  three  90-pin  DMF  chips,  and  a  device  spacer.  The  DropBot 
instrument  used  an  integrated  high-voltage  source  for  a  maximum  of  140  V rms   at  100  Hz 
to  10  kHz.  The  system  was  controlled  by  open  source  MicroDrop  software  [45] .  Standard 
90-pin  DMF  chips  are  made  by  Sci-Bots  for  the  DropBot  DB3-120.  The  DMF  chips  have 
a  two-plate  configuration  with  a  180  μm  gap  height.  The  bottom  plate  uses  a  0.9  mm 
soda-lime  glass  substrate,  chrome  electrodes,  Parylene-C  dielectric  layer  with  6  µm 
thickness,  and  FluoroPel  hydrophobic  layer  (Cytonix  Corporation,  Beltsville,  MD,  USA). 
The  top  plate  is  a  0.7  mm  ITO-coated  glass  slide  with  a  FluoroPel  hydrophobic  layer,  and 
the  gap  spacing  between  the  two  plates  is  180  μm.  The  DMF  chip  had  a  symmetric  layout 
with  8  reservoirs  and  76  addressable  electrodes.  The  electrodes  patterned  on  the  bottom 
slide  of  the  chip  are  2  mm  x  2  mm  squares  with  a  zigzag  interface  between  electrodes.  As 
shown  in  Figure  1,  the  chip  was  divided  into  four  test  sites.  
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Figure  1.  DMF  chip  electrode  layout  describing  the  locations  of  the  test  sites. 
4.2  Sample  Preparation 
All  blood  acquired  was  compliant  with  the  approved  F16134  San  Jose  State 
Institutional  Review  Board  (IRB)  protocol.  All  fluid  specimens  were  dispensed  using  a 
Fisherbrand  Finnpipette  II  (0.5-10  μL)  with  disposable  Fisherbrand  Micro  Pipet  tips.  All 
liquid  specimens  actuated  on  the  DMF  platform  had  an  addition  of  0.1%  ethylenediamine 
tetrakis  (ethoxylate-block-propoxylate)  tetrol  (Tetronic  90R4,  MilliporeSigma, 
Burlington,  MA).  The  volume  dispensed  by  pipette  has  a  resolution  of  0.1  µL. 
4.2.1  PBS 
PBS  specimens  were  created  from  PBS  with  0.2%  added  surfactant.  As  the  surfactant 
was  very  viscous,  adding  such  small  amounts  to  the  solution  presented  a  challenge.  To 
create  specimens,  the  surfactant  ethylenediamine  tetrakis  (ethoxylate-block-propoxylate) 
tetrol  (Tetronic  90R4,  MilliporeSigma,  Burlington,  MA)  was  dispensed  into  a 
microcentrifuge  tube,  using  a  scale  to  record  weight.  Using  the  recorded  weight,  PBS  was 
16 
dispensed  into  the  microcentrifuge  tube  by  pipette,  then  mixed  using  a  vortex  mixer  at 
3000  rpm  for  15  s.  PBS  specimens  were  dyed  with  fluorescein  (MilliporeSigma).  To  dye, 
fluorescein  was  added  by  pipette  to  PBS  at  1:20  by  volume  and  mixed  using  a  vortex 
mixer  at  3000  rpm  for  15  s. 
4.2.2  Whole  Blood 
Whole  blood  specimens  were  made  from  whole  blood  diluted  1:40  in  PBS  with  0.2% 
surfactant.  To  create  specimens,  ethylenediamine  tetrakis  (ethoxylate-block-propoxylate) 
tetrol  was  dispensed  into  a  microcentrifuge  tube,  using  a  scale  to  record  weight.  Using  the 
recorded  weight,  PBS  was  dispensed  into  the  microcentrifuge  tube  by  pipette,  then  mixed 
using  a  vortex  mixer  for  250  relative  centrifugal  force  (RCF)  for  20  min.  Finally,  whole 
blood  was  dispensed  by  the  pipette  into  the  microcentrifuge  tube  and  mixed  by  pipette. 
4.2.3  RBC  Suspensions 
RBC  specimens  were  made  from  RBCs  diluted  in  PBS  with  0.2%  surfactant.  To 
separate  RBCs  from  whole  blood,  blood  specimens  were  spun  in  a  centrifuge  set  to  a 
force  of  250  RCF  for  20  min.  Plasma  and  white  blood  cell  layers  were  removed  by 
pipette.  To  wash  RBCs,  100  µL  of  RBCs  was  added  to  1  mL  of  PBS,  then  spun  in  a 
centrifuge  set  to  a  force  of  250  times  gravity  for  20  min.  The  PBS  was  removed  by 
pipette.  All  RBCs  were  washed  twice  and  then  diluted  to  specification  in  PBS.  To  create 
specimens,  ethylenediamine  tetrakis  (ethoxylate-block-propoxylate)  tetrol  (Tetronic 
90R4,  MilliporeSigma,  Burlington,  MA)  was  dispensed  into  a  microcentrifuge  tube, 
using  a  scale  to  record  weight.  Using  the  recorded  weight,  PBS  was  dispensed  into  the 
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microcentrifuge  tube  by  pipette,  then  mixed  using  a  vortex  mixer.  Finally,  the  washed 
RBCs  were  dispensed  by  pipette  into  the  microcentrifuge  tube  and  mixed  by  pipette. 
4.2.4  Neuraminidase  Treatment 
RBCs  were  treated  with  neuraminidase  to  remove  surface  charge.  First,  the  cells  were 
separated  from  whole  blood  and  washed.  Next,  neuraminidase  (MilliporeSigma)  was 
added  at  a  dosage  of  100  mU/mL,  to  the  RBC  suspension.  For  neuraminidase  stock  of  2 
U/mL,  1  µL  of  neuraminidase  stock  was  added  for  every  20  µL  of  RBC  suspension.  The 
suspension  was  mixed  by  pipette  and  incubated  in  a  water  bath  for  30  min  at  37  °C. 
Finally,  the  cells  were  washed  twice  by  adding  PBS  and  centrifuging  to  remove  the 
neuraminidase.  The  resulting  RBC  suspension  was  then  used  to  create  rheometry  and 
tensile  test  solutions  as  described. 
4.3  Experimental  Protocol 
Experimental  tensile  tests  on  all  specimens  were  performed  on  the  DropBot  DMF 
platform.  Each  test  was  performed  on  an  unused  site  in  order  to  avoid  biofouling.  Tensile 
tests  were  conducted  on  designated  sites  on  the  EWOD  chip  as  shown  in  Figure  1.  As 
each  chip  had  eight  reservoirs  and  four  test  sites,  four  tensile  tests  could  be  conducted 
simultaneously  on  a  chip.  Each  tensile  test  began  by  applying  the  prescribed  voltage  to 
the  respective  reservoir.  Each  of  the  four  reservoirs  received  5.5  μL  of  liquid  specimen 
dispensed  by  pipette.  Next,  all  specimens  were  actuated  into  the  test  position  as  shown  in 
Figure  2  from  the  reservoir  using  an  actuation  voltage  between  80  V  and  100  V.  Finally, 
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the  specimens  were  put  under  tension  by  activating  electrodes  as  seen  in  Figure  2  at  100 
V rms   and  10  kHz,  maintaining  voltage  until  the  specimens  split  or  reached  equilibrium. 
 
Figure  2.  Electrode  sequence  for  actuating  liquid  specimens  into  the  necessary  position 
for  a  tensile  test.  Each  lettered  region  represents  an  electrode,  with  shaded  regions 





Figure  3.  Electrode  sequence  for  tensile  test  on  a  test  site.  Each  lettered  region  represents 
an  electrode,  with  shaded  regions  indicating  an  activated  electrode. 
4.3.1  PBS  Tensile  Tests 
Tensile  tests  on  PBS  specimens  were  performed  on  the  DropBot,  ensuring  an 
untouched  chip  was  used  to  avoid  effects  of  biofouling.  Approximately  5  μL  of  PBS 
specimen  was  dispensed  into  an  activated  reservoir  on  each  test  site.  For  fluorescent 
imaging,  a  light  shield  was  placed  over  the  DropBot  prior  to  specimen  actuation. 
Specimens  were  actuated  into  position  as  per  Figure  2  and  tensile  tested  as  per  Figure  3. 
As  described  in  Appendix  1,  PBS  specimens  were  tested  on  two  chips,  with  tests 
conducted  on  four  sites  on  each  chip. 
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4.3.2  RBC  and  Whole  Blood  Tensile  Tests 
Tensile  tests  on  RBC  and  whole  blood  specimens  were  performed  on  the  DropBot, 
ensuring  an  untouched  chip  was  used  to  avoid  effects  of  biofouling  [31] .  Approximately 
5  μL  of  each  liquid  specimen  was  dispensed  into  an  activated  reservoir  on  each  test  site. 
Specimens  were  actuated  into  position  as  per  Figure  2  and  tensile  tested  as  per  Figure  3. 
Whole  blood  tensile  tests  were  conducted  on  four  sites  one  one  chip.  RBC  tensile  tests 
were  conducted  using  blood  drawn  from  two  donors.  Neuraminidase-treated  RBC 
suspensions  were  tested  over  two  chips  and  untreated  RBC  suspensions  were  tested  over 
two  separate  chips.  Tests  were  conducted  on  four  unique  site  on  each  chip,  ensuring  cells 
from  each  donor  were  tested  on  both  chips. 
4.3.3  Rheometry 
Oscillatory  rheometry  experiments  were  performed  on  neuraminidase-treated  RBCs 
to  examine  the  rheological  effects  of  the  treatment.  An  oscillatory  viscometer  (Anton 
Paar  MCR  302,  Anton  Paar  GmbH,  Graz,  Austria)  was  used  to  measure  the  loss  modulus 
against  shear  for  neuraminidase-treated  RBC  suspension  and  untreated  RBC  suspension. 
To  prepare  suspensions,  whole  blood  was  spun  in  a  centrifuge  for  20  min  at  250  times  the 
force  of  gravity  to  separate  RBC,  plasma,  and  leukocyte  layers.  The  plasma  and 
leukocyte  layers  were  extracted  and  the  RBCs  were  washed  twice  by  creating  a  solution 
of  10%  RBCs  suspended  in  PBS,  centrifuging,  and  removing  supernatant  by  pipette. 
From  the  washed  RBC  suspension,  1  mL  of  cells  was  extracted  and  treated  with 
neuraminidase.  Experiments  were  performed  on  cell  solutions  with  (platelet-rich)  plasma. 
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Suspensions  were  10%  RBCs  with  50%  PBS  and  40%  plasma  by  volume,  and  10% 
RBCs  with  90%  plasma  by  volume.  The  justification  for  observing  solutions  with  these 
differing  concentrations  of  plasma  is  that  in  the  absence  of  plasma,  Jan  and  Chien  [33] 
observed  that  the  difference  between  neuraminidase-treated  RBCs  and  untreated  RBCs, 
both  suspended  in  saline,  was  not  discernible  until  a  polymer  solution  (Dextrans  20,  40, 
and  80)  were  added.  Wen  et  al.  [34]  conducted  a  similar  experiment  with  rabbit  red  blood 
cells  suspended  in  plasma  at  H=35%.  In  this  experiment,  both  suspensions  were  run  with 
both  treated  and  untreated  cells.  An  amplitude  sweep  was  performed  over  a  range  of 
strains  from  0.01%  to  500%  at  an  angular  frequency  of  10  rad/s.  A  parallel  plate 




5.  RESULTS  AND  DISCUSSION 
The  blood  specimens  were  subjected  to  tension  on  the  EWOD-based  DMF  platform. 
Figure  4  shows  an  example  of  the  time  progression  of  necking  over  the  duration  of  a 
tensile  test.  As  Figure  4  shows,  the  profile  had  an  effective  neck  width  of  the  electrode 
width  and  an  infinite  neck  radius  prior  to  actuation.  As  the  electrodes  were  activated, 
liquid  moves  towards  the  activated  electrodes,  causing  necking  over  the  two  deactivated 
electrodes. 
    
Figure  4.  Example  of  the  time  progression  of  necking  during  an  on-chip  tensile  test.  The 
specimen  pictured  is  whole  blood  diluted  1:20  in  PBS. 
5.1  Parameter  Extraction 
Due  to  high  variability  in  the  time  development  of  the  necking  profile  between  sites 
on  a  DMF  chip,  a  time-invariant  deformation  parameter  is  valuable.  The  parameters 
measured  to  describe  the  necking  profile  were  the  minimum  neck  width  d  and  radius  of 
the  necking  profile  R  as  illustrated  in  Figure  5.  
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Figure  5.  Illustration  of  necking  parameters  measured  during  tests,  where  d  is  the 
minimum  neck  width,  and  R  is  the  radius  of  the  necking  profile. 
Both  the  neck  radius  and  neck  width  were  obtained  from  microscope  video.  Frames 
from  recorded  video  were  extracted  at  regular  intervals  using  the  FFmpeg  tool  [46] .  The 
resulting  images  were  processed  using  ImageJ  software  [47] .  First,  the  frame  was 
cropped  to  isolate  a  test  site.  Next,  a  color  deconvolution  [48]  was  used  to  separate  the 
pigmentation  of  the  liquid  such  that  the  profile  can  be  extracted.  The  image  was  then 
noise-reduced  and  binarized.  To  obtain  the  neck  radius,  the  necking  profile  was  extracted 
from  the  binarized  image  as  a  separate  left  and  right  profile.  A  robust  circle  fit  method 
[49],  [50]   was  used  to  fit  a  circle  to  both  the  left  and  right  profile.  Due  to  asymmetry 
between  the  left  and  right  sides  of  the  profile,  the  radius  value  for  each  frame  was  taken 
as  the  average  of  the  radius  from  both  sides  of  the  profile.  The  neck  width  was  obtained 
by  measuring  the  width  of  the  profile  over  the  entire  neck.  The  smallest  measured  width 
for  each  frame  was  taken  as  the  neck  width  value  for  that  frame. 
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5.2  Time  Development  of  the  Necking  Profile 
Tensile  tests  were  evaluated  on  the  DMF  platform  for  PBS,  whole  blood,  and  RBC 
suspensions.  The  development  of  the  necking  profile  was  observed  by  measuring  the 
minimum  neck  width  of  each  droplet  specimen  under  tension  over  the  progression  of  the 
experiment.  Figure  6  shows  the  neck  width  versus  time  for  pure  PBS.  Tests  were 
performed  on  unique  sites  over  two  distinct  DMF  chips.  In  addition  to  a  high  run-to-run 
variability,  the  results  show  a  high  chip-to-chip  variability  (runs  1  through  4  were 
performed  on  one  chip,  while  runs  5  through  7  were  performed  on  separate  chip).  
 
Figure  6.  Neck  width  versus  time  for  tensile  tests  on  PBS.  
As  shown  in  Figure  7,  tensile  test  results  on  whole  blood  showed  similar  variation 
across  runs.  Whole  blood  diluted  1:20  in  PBS  was  tested  across  four  sites  on  one  chip.  As 
Figure  7  shows,  the  necking  development  slowed  dramatically  with  each  run,  suggesting 




Figure  7.  Neck  width  versus  time  for  tensile  tests  on  whole  blood  diluted  at  a  1:20 
dilution.  
Tensile  tests  were  performed  on  RBCs  collected  from  two  donors.  Cells  from  each 
donor  were  tested  over  multiple  distinct  lanes  on  two  different  chips  as  in  Appendix  1. 
Figure  8  shows  the  time  development  of  the  necking  profile  over  each  run.  No  significant 
difference  was  observed  between  donor  1  and  donor  2.  Runs  in  which  the  liquid 
specimen  reached  equilibrium  under  tension  show  a  horizontal  asymptote  (run  1  and  run 
3)  while  runs  in  which  the  liquid  specimen  split  show  a  neck  width  trending  to  zero  (run 
2,  run  4,  run  5,  and  run  6). 
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Figure  8.  Neck  width  versus  time  for  tensile  tests  on  RBC  suspensions  at  H=10%. 
5.3  Time-Invariant  Development  of  Necking  Profile 
To  obtain  time-invariant  observations  of  experiments,  tensile  tests  were  analyzed 
using  characteristic  geometric  parameters  of  the  necking  profile,  neck  radius  and  neck 
width.  A  three-parameter  exponential  model  (14)  was  fitted  to  experimental  data  from 
each  experimental  substance.  
 (14) 
Figure  9  shows  the  neck  radius  plotted  against  neck  width  for  the  same  set  of  PBS  tensile 
tests  shown  in  Figure  5.  As  expected,  the  neck  radius  decreased  with  neck  width.  The 
exponential  fit  matched  well  with  experimental  data.  Neck  radius  values  were  very  close 
for  all  runs,  but  spread  further  apart  at  neck  widths  from  about  1.25  mm  to  1.5  mm.  
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Figure  9.  Neck  radius  versus  neck  width  for  tensile  tests  on  PBS. 
Whole  blood  neck  radius  versus  neck  width  plots  are  shown  in  Figure  10  and  Figure 
11.  Neck  radius  versus  neck  width  measurements  for  whole  blood  diluted  1:20  (shown  in 
Figure  10)  are  from  the  same  tensile  test  runs  as  shown  in  Figure  6.  Tensile  tests  were 
conducted  on  whole  blood  at  dilutions  of  1:20  (Figure  10)  and  1:10  (Figure  11).  Figure  11 
shows  the  neck  radius  decreasing  as  the  neck  width  decreased,  as  expected.  The  neck 
radius  for  whole  blood  diluted  1:20  approached  4.48  mm  at  low  neck  width  values. 
Measurements  for  each  run  were  close  together,  and  the  exponential  fit  matched  the 
experimental  data  well.  
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Figure  10.  Neck  radius  versus  neck  width  on  whole  blood  diluted  1:20. 
 
Figure  11.  Neck  radius  versus  neck  width  for  tensile  tests  on  whole  blood  diluted  1:10. 
Figure  11  shows  the  neck  radius  versus  neck  width  for  whole  blood  diluted  1:10. 
Similarly  to  PBS  and  whole  blood  1:20,  measurements  between  runs  are  close  together. 
The  exponential  fit  also  matches  the  data  well.  Compared  to  whole  blood  1:20,  whole 
blood  1:10  saw  a  steeper  rise  in  neck  radius  as  neck  width  increased.  The  parameters 
from  the  exponential  fit  can  be  compared  from  Table  1.  For  whole  blood  1:20,  C 2   =  2.81 
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mm -1  while  for  whole  blood  1:10,  C 2   =  4.13  mm -1 .  Furthermore,  the  horizontal  asymptote 
for  whole  blood  1:10  was  at  a  neck  radius  of  4.97  mm.  This  was  slightly  larger  than  the 
horizontal  asymptote  for  whole  blood  1:20,  at  a  neck  radius  of  4.48  mm.  This  represents 
the  neck  radius  to  which  the  liquid  specimen  approaches  as  the  neck  width  approaches  0 
mm  and  the  specimen  splits. 
Figure  12  and  Figure  13  show  neck  radius  versus  neck  width  results  for  RBC 
suspensions  with  hematocrit  H=10%.  Figure  13  shows  the  results  for  cells  treated  with 
neuraminidase  to  remove  surface  charge  and  Figure  12  shows  the  results  for  untreated 
cells.  The  results  shown  in  Figure  12  were  obtained  from  the  same  tensile  test  runs  as 
shown  in  Figure  8.  In  Figure  12,  run  1  through  run  3  were  performed  a  distinct  DMF  chip 
from  run  4  through  run  6.  No  dependency  on  DMF  chip  or  run  is  observed  in  Figure  12 
or  Figure  13. 
 






Figure  13.  Neck  radius  versus  neck  width  for  tensile  tests  on  neuraminidase-treated  RBC 
suspensions  at  H=10%. 
Table  1  reports  parameters  for  exponential  fit  (14)  on  all  neck  radius  versus  neck 
width  results.  Whole  blood  1:10  had  the  smallest  value  for  C 1   while  PBS  had  the  largest 
value  for  C 1 .  Whole  blood  1:10  also  had  the  largest  value  for  the  exponential  parameter 
C 2 ,  while  PBS  and  untreated  RBCs  had  the  smallest  value  for  C 2  .  Compared  to  whole 
blood  1:20,  whole  blood  1:10  had  a  lower  value  for  C 1   and  higher  values  for  C 2   and  C 3 . 
Similarly,  neuraminidase-treated  RBCs  had  a  lower  value  for  C 1   and  higher  values  for  C 2  
and  C 3   in  comparison  to  untreated  RBCs.  Of  all  materials  tested,  PBS  had  the  highest 
value  of  C 1   and  lowest  values  of  C 2   and  C 3 .  
Table  1.  Parameter  Values  for  Exponential  Fits  to  Tensile  Tests. 
Parameter PBS Whole Blood  1:20 
Whole 




Treated  RBCs 
C 1   [mm] 1.08 0.108 0.00670 0.880 0.0840 
C 2   [mm -1 ] 1.47 2.81 4.13 1.47 2.94 
C 3   [mm] 3.15 4.48 4.97 3.48 4.11 
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5.4  Neuraminidase  Treatment  of  Red  Blood  Cells 
The  treatment  of  RBCs  with  neuraminidase  is  intended  to  remove  the  cells’  negative 
surface  charge  by  cleaving  sialic  acid  from  the  surface  of  the  cells  [16] .  Rheometry 
experiments  and  microscope  images  were  used  to  observe  the  effects  of  neuraminidase 
treatment  on  the  rheology  of  RBC  suspensions.  RBCs  were  suspended  in  two  solutions 
with  varying  amounts  of  plasma  as  described.  Figure  14  shows  microscope  images 
comparing  images  of  untreated  and  neuraminidase-treated  cells  suspended  in  plasma. 
Both  images  showed  rouleaux  formation,  with  the  neuraminidase-treated  cells  having 
slightly  larger  rouleaux  stacks.  No  large  differences  in  cell  aggregation  were  observed. 
Untreated Neuraminidase-Treated 
  
Figure  14.  Untreated  and  neuraminidase-treated  RBC  suspensions  in  plasma  with 









Figure  15.  Untreated  and  neuraminidase-treated  RBC  suspensions  of  40%  plasma,  50% 
PBS,  and  10%  cells  by  volume.  The  scale  bar  in  the  bottom  left  corner  of  each  image  is 
25  μm  long. 
Figure  15  shows  microscope  images  comparing  images  of  untreated  and 
neuraminidase-treated  cells  in  a  suspension  of  plasma  and  PBS  at  H=10%.  The  solution 
was  50%  PBS,  40%  plasma,  and  10%  cells  by  volume.  No  rouleaux  formation  was 
observed  in  the  untreated  cells  while  rouleaux  formation  was  observed  in  the 
neuraminidase-treated  cells.  The  increased  presence  of  cell  aggregates  in  the 
neuraminidase-treated  cells  demonstrates  the  effect  of  the  treatment,  which  is  expected  to 
increase  cell  agglutination  [16] .  
Rheometry  experiments  were  conducted  on  an  oscillatory  parallel  plate  rheometer 
(Anton  Paar  GmbH)  using  a  15  mm  parallel  plate  measuring  system.  Tests  were 
conducted  on  RBC  suspensions  at  H=10%.  Solutions  were  50%  PBS,  40%  plasma,  and 
10%  cells  by  volume,  and  cells  were  tested  from  two  separate  donors.  An  amplitude 
sweep  was  performed  over  applied  strain  values  ranging  from  0.01%  to  500%,  measuring 
peak  shear  stress.  The  angular  frequency  was  10  rad/s  for  all  experiments.  The  difference 
between  shear  stress  in  untreated  and  neuraminidase-treated  specimens  over  1%  to  300% 
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shear  strain  is  shown  in  Figure  16.  As  shown  in  Figure  16,  the  neuraminidase-treated 
cells  had  a  larger  shear  stress  response  compared  to  untreated  cells  over  the  interval  of 
shear  strain  values. 
 
Figure  16.  Peak  shear  stress  versus  shear  strain  for  RBC  suspensions  treated  with 
neuraminidase  and  untreated  RBC  suspensions. 
The  result  of  the  rheometry  experiments  demonstrate  an  increased  shear  stress 
response  to  applied  shear  strain  in  neuraminidase-treated  RBCs  in  comparison  to 
untreated  RBCs.  This  change  in  the  rheology  of  cells  is  further  shown  by  Figure  15, 
which  shows  the  increase  in  cell  aggregation  in  neuraminidase-treated  RBCs. 
5.5  Estimation  of  Electrowetting  Force 
The  force  acting  on  liquid  specimens  can  be  estimated  by  the  electrowetting  force 
acting  on  the  droplet.  The  electrowetting  force  acts  along  the  contact  line  between  the 
liquid  and  electrode  boundary,  so  the  electrowetting  force  was  estimated  at  maximum 
contact  between  the  liquid  and  electrode.  The  line  force  f w   can  be  calculated  from 
34 
equation  (3)  in  terms  of  the  contact  angle  change,  and  integrating  f w   over  the  maximum 
contact  line  per  equation  (4)  results  in  the  total  electrowetting  force  acting  on  the  liquid 
(5).  To  determine  an  estimation  of  the  electrowetting  force  on  whole  blood,  determining 
the  surface  tension  of  blood  is  necessary.  The  surface  tension  γ  of  whole  blood  can  be 
described  by  a  linear  relationship  with  temperature  T  [51] . 
 (15) 
Per  Li  et  al.,  the  estimated  contact  angle  change  for  an  applied  voltage  of  100  V  is  23.5° 
[19] .  Using  these  values  with  equation  (5)  results  in  a  maximum  electrowetting  force  of 
45.8  μN  acting  on  a  blood  droplet  specimen  when  100  V  is  applied. 
5.6  Discussion 
The  time  results  of  tensile  tests  showed  higher  variability  as  well  as  dependence  on 
DMF  chip  and  site  in  comparison  to  time-invariant  results.  This  was  shown  to  occur  in 
PBS,  whole  blood,  and  RBC  suspensions.  Furthermore,  whole  blood  and  RBC  specimens 
were  observed  to  separate  by  component  during  testing  on  DMF  chips.  This  phenomenon 
was  investigated  using  the  color  profile  of  the  neck  during  tensile  tests  on  RBC 
suspensions. 
5.6.1  Variability  in  Tensile  Behavior 
Evaluating  the  neck  width  against  time  over  the  duration  of  a  tensile  test  on  a  DMF 
platform  results  in  a  profile  which  showed  a  high  dependence  on  the  site  and  chip  on 
which  the  test  was  run.  Particularly  for  whole  blood  tensile  tests,  the  duration  of  a  tensile 
test  ranged  from  seconds  to  dozens  of  minutes.  In  each  case,  this  could  be  due  to  several 
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factors.  One  such  factor  is  local  microtopography  of  hydrophobic  coatings  on  the  top  and 
bottom  plate  of  the  chip,  which  can  be  very  influential  on  the  droplet  behavior  [52] . 
Another  factor  is  the  parallelism  between  the  top  and  bottom  plate  of  the  chip,  which 
varies  the  gap  spacing  between  plates.  This  highly  affects  the  capacitance  (3)  of  the 
circuit  made  by  the  electrodes,  dielectric  layer,  and  liquid. 
The  time-invariant  method  produced  results  with  no  observed  dependence  on  test  site 
or  chip.  In  addition,  the  development  of  geometric  parameters  was  far  closer  between 
runs.  This  gives  the  time-invariant  method  of  observation  on  a  DMF  platform  value  in 
comparison  to  time  measurement,  as  it  removes  the  high  time  variability.  An  exponential 
fit  with  three  parameters  (14)  matched  measured  data  well  for  PBS,  whole  blood,  and 
RBC  suspension  tensile  tests.  Whole  blood  diluted  1:10  experienced  a  steeper 
exponential  increase,  with  a  C 2   value  of  4.13  mm -1 ,  compared  to  whole  blood  diluted 
1:20,  with  a  C 2   value  of  2.81  mm -1 .  Additionally,  whole  blood  1:10  had  a  smaller  C 1   value 
and  larger  C 3   value  than  whole  blood  1:20.  Following  this  trend,  PBS  had  a  larger  C 1  
value,  smaller  C 2   value,  and  smaller  C 3   value.  This  indicates  that  the  concentration  of 
blood  in  a  liquid  specimen  tested  on  a  DMF  device  influences  the  development  of  the 
necking  profile,  and  has  potential  for  developing  further  testing  methods. 
Tensile  tests  on  RBC  suspensions  did  not  see  any  dependence  on  donor.  The  untreated 
RBC  suspensions  had  a  higher  C 1   value,  a  lower  C 2   value,  and  a  lower  C 3   value  compared 
to  neuraminidase-treated  RBC  suspensions.  This  suggests  that  the  untreated  cells  behaved 
closer  to  pure  PBS,  while  the  treated  cells  behaved  closer  to  whole  blood.  The 
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neuraminidase  treatment  was  observed  in  Figure  14  to  slightly  increase  the  cells’ 
tendency  to  aggregate,  and  Figure  15  demonstrates  the  effect  on  the  rheology  of  RBC 
suspensions.  The  rheometry  results  in  addition  to  the  increased  agglutinability  observed 
in  neuraminidase-treated  RBCs  show  that  the  altered  rheology  of  treated  RBCs  affected 
the  development  of  the  necking  profile  during  tensile  tests.  The  increased  agglutinability 
of  cells  has  been  shown  to  increase  viscosity  within  a  suspension  [16],  [34],  [53] .  The 
increased  viscosity  in  treated  RBC  suspensions  is  consistent  with  a  larger  minimum  neck 
radius  in  comparison  to  untreated  RBC  suspensions,  quantified  by  C 3   in  the  exponential 
fit.  The  influence  of  viscosity  between  untreated  and  treated  RBCs  suggests  that  the 
comparison  between  dilutions  of  whole  blood  are  also  influenced  by  viscosity,  as  the 
exponential  parameter  comparison  follows  the  same  pattern. 
Notable  is  the  varied  behavior  of  different  substances  on  a  DMF  platform.  RBC 
suspensions  and  PBS  exhibited  the  fastest  response  to  electrowetting  actuation,  followed 
by  whole  blood  and  fresh-frozen  plasma  (FFP).  FFP  was  used  exclusively  during 
preliminary  tests  over  the  course  of  this  study,  but  proved  highly  difficult  to  actuate 
consistently  on-chip,  often  requiring  high  actuation  voltages  for  a  response.  Additionally, 
FFP  was  observed  to  gradually  change  from  transparent  to  opaque  and  reduce  response 
while  under  applied  electrowetting  over  several  minutes.  While  several  tensile 
experimental  protocols  were  developed  for  FFP,  the  challenges  of  reliably  transporting 
FFP  specimens  to  test  sites  on-chip  caused  these  experiments  to  be  impractical.  
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5.6.2  Component  Separation 
Observed  in  several  tensile  tests  was  the  separation  of  components  within  whole 
blood  and  RBC  suspensions.  Figure  17  shows  an  example  of  this  separation  which 
occurred  in  whole  blood  diluted  1:10  on  repeat  tensile  testing.  This  is  likely  due  to  the 
differences  in  response  of  RBCs,  plasma,  and  PBS  to  the  applied  electrowetting  forces. 
 
Figure  17.  Development  of  component  separation  during  tensile  testing  on  whole  blood 
diluted  1:10.  
Additionally,  this  separation  of  components  can  plausibly  explain  the  difficulties  of 
actuating  whole  blood  relative  to  PBS  and  RBC  suspensions.  Whole  blood  includes 
plasma,  which  had  a  low  response  to  electrowetting  forces,  but  also  contains  RBCs,  and 
is  then  diluted  in  PBS.  This  effect  offers  further  potential  to  analyze  the  components  of 
blood  and  their  behavior  within  an  applied  electric  field. 
The  separation  between  components  was  further  observed  in  additional  tensile  tests 
performed  on  untreated  and  neuraminidase-treated  RBC  suspensions.  Due  to  the  fast 
response  to  tensile  force  in  both  the  treated  and  untreated  RBC  suspensions,  testing  was 
conducted  by  performing  two  consecutive  tensile  tests  on  each  suspension  on  the  same 
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site,  with  30  s  between  each  test.  Figure  18  shows  the  separation  in  untreated  RBCs  at 
each  tensile  test  by  showing  the  suspension  at  the  same  neck  width  for  both  tests.  The 
normalized  level  for  the  red  channel  of  the  captured  RGB  (red,  green,  and  blue)  image 
remained  near  1.0  for  across  the  neck  width  the  first  tensile  test,  but  had  a  distinct  valley 







Figure  18.  Separation  of  an  untreated  RBC  suspension  at  H=10%  over  two  consecutive 
tensile  tests.  The  image  and  plot  at  (a)  and  (b)  show  the  suspension  during  the  first  and 
second  tensile  test,  respectively,  at  the  same  neck  width.  The  plots  show  the  normalized 
red  level  extracted  from  the  image  across  the  minimum  neck  width. 
The  neuraminidase-treated  RBC  suspension  experienced  a  greater  separation  than  the 
untreated  suspension.  In  Figure  19,  which  shows  the  separation  of  a  treated  suspension, 
the  change  between  the  consecutive  tensile  tests  is  greater  than  the  corresponding  images 
in  Figure  18,  which  shows  the  separation  in  an  untreated  suspension.  This  separation  is 
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confirmed  in  the  normalized  red  level  plots  for  both  suspensions.  The  minimum  red  level 
for  the  separated  untreated  suspension  was  0.21,  while  the  minimum  red  level  for  the 
separated  treated  suspension  was  below  0.10.  The  neuraminidase  treatment  caused  an 
increased  cell  agglutination,  which  was  confirmed  in  Figure  14  and  Figure  15.  A  likely 
factor  in  the  increased  separation  is  the  presence  of  larger  cell  aggregates  in  the 
neuraminidase-treated  RBC  suspensions.  Additionally,  a  decreased  repulsive  force 
between  cells  increased  their  tendency  to  move  towards  the  sides  of  the  neck  in  the 
treated  suspensions.  In  the  untreated  RBC  suspensions,  the  cells  retained  their  regular 
repulsive  force  and  did  not  have  an  increased  tendency  to  aggregate,  leading  to  less 










Figure  19.  Separation  of  a  neuraminidase-treated  RBC  suspension  at  H=10%  over  two 
consecutive  tensile  tests.  The  image  and  plot  at  (a)  and  (b)  show  the  suspension  during 
the  first  and  second  tensile  test  at  the  same  neck  width.  The  plots  show  the  normalized 
red  value  extracted  from  the  image  across  the  minimum  neck  width. 
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6.  CONCLUSIONS 
A  time-invariant  method  was  developed  to  observe  the  development  of  the  necking 
geometry  of  liquid  specimens  on  an  electrowetting  DMF  platform.  This  method  was 
based  on  applying  electrowetting  force  such  that  the  liquid  specimen  is  in  tension,  and 
evaluating  the  neck  radius  against  the  neck  width  over  the  evolution  of  the  specimen’s 
deformation.  Tensile  tests  were  performed  on  PBS,  whole  blood  diluted  1:20  in  PBS,  and 
RBCs  suspended  in  PBS  at  H=10%.  The  time  evolution  of  liquid  necking  was  evaluated 
by  measuring  the  neck  width  against  time.  For  all  substances,  this  was  shown  to  have  a 
high  dependence  on  the  site  and  DMF  chip  on  which  the  test  was  performed.  The 
time-invariant  method  was  then  used  and  compared  to  the  time  evolution  for  PBS,  whole 
blood,  and  RBC  specimens.  In  comparison  to  the  time  evolution,  the  time-invariant  data 
saw  dramatically  decreased  variability  between  runs  as  well  as  no  dependence  on  test  site 
or  chip.  Due  to  this,  the  time-invariant  method  using  the  geometry  of  the  necking  profile 
provides  a  way  to  evaluate  liquid  specimens  on  a  DMF  platform  which  mitigates  inherent 
difficulties  of  electrowetting-based  testing,  including  local  topography  of  layers  on  DMF 
chips  and  parallelism  between  the  top  and  bottom  plate  of  a  two-plate  DMF  system. 
Tensile  tests  on  a  DMF  platform  were  used  to  observe  the  influence  of  RBC  surface 
charge  on  the  development  of  necking.  To  remove  surface  charge,  RBCs  were  treated 
with  neuraminidase.  Microscope  images  showed  a  slight  increase  in  cell  aggregates  in 
neuraminidase-treated  RBCs,  and  parallel-plate  rheometry  showed  an  increased  shear 
stress  response  to  applied  strain.  Neck  width  versus  neck  radius  results  were  compared 
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between  treated  and  untreated  RBC  suspensions  using  a  three-parameter  exponential  fit 
to  experimental  data.  Neuraminidase-treated  RBCs  had  a  lower  scaling  parameter  C 1  
value,  a  higher  exponential  parameter  C 2   value,  and  a  higher  minimum  neck  radius 
parameter  C 3   value  than  untreated  RBCs,  indicating  a  more  slender  aspect  ratio  over  the 
duration  of  the  tensile  tests.  This  is  consistent  with  neuraminidase-treated  RBCs  having  a 
greater  tendency  to  aggregate  and  consequently  exhibit  higher  viscosity.  The  necking 
development  was  also  compared  between  whole  blood  at  different  concentrations  using 
the  exponential  fit  to  experimental  data.  Whole  blood  diluted  1:20  had  a  higher  C 1   value, 
a  lower  C 2   value,  and  lower  C 3   value  in  comparison  to  whole  blood  diluted  1:10.  This 
follows  the  trend  of  the  RBC  parameter  comparison,  with  whole  blood  1:20  and  untreated 
RBC  suspensions  having  a  lower  viscosity  than  whole  blood  1:10  and  treated  RBC 
suspensions  having  a  higher  viscosity.  These  results  support  the  hypothesis  that 
independent  of  time,  a  characteristic  necking  profile  exists  for  whole  blood  and  RBC 
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Chip Site  1 Site  2 Site  3 Site  4 
PBS Chip  1 No  Donor No  Donor No  Donor No  Donor 
PBS Chip  2 No  Donor No  Donor No  Donor No  Donor 
Whole  Blood  1:20 Chip  7 Donor  3 Donor  3 Donor  3 Donor  3 
Whole  Blood  1:10 Chip  8 Donor  4 Donor  4 - - 
Untreated  RBC Chip  3 Donor  1  Donor  2 Donor  1 Donor  2 
Untreated  RBC Chip  4 Donor  2 Donor  1 Donor  2 Donor  1 
Treated  RBC Chip  5 Donor  1  Donor  2 Donor  1 Donor  2 





APPENDIX  B:   Electronic  Lab  Notebook 
 
20180917  location  of  hydrophobic  coating  on  DropBot  chip 
 
As  shown  in  recorded  images,  there  is  a  visible  edge  to  the  hydrophobic  layer  on  the  chip. 
A  line  showing  the  edge  of  the  hydrophobic  layer  is  seen  about  halfway  between  the 
reservoirs  and  the  innermost  contact  pads,  running  parallel  to  the  short  edge  of  the  chip. 
DropBot  chip  used  was  f7660e8e-1872-43f8-ab23-267de2c4759a  (759a). 
 
 
20180921  droplet  actuation  on  DropBot  chip  with  propylene  glycol 
 
Used  propylene  glycol  on  (new)  DropBot  frame  with  chip  759a.  Achieved  full  droplet 
control  (creation,  motion,  etc.)  with  100  V.  Videos  were  captured  using  the  AmScope 
MU8000. 
 
Videos  recorded  in  Google  Drive. 
 
 
20180927  attempted  droplet  “clotting  test”  over  electrode 
 
Previously  discussed  was  a  method  to  test  sample  clotting  state  by  moving  the  droplet 
sample  over  a  single  electrode,  de-actuating  to  recover  a  circular  shape,  then  actuating 
two  adjacent  electrodes  on  either  side  to  deform  the  droplet.  The  metric  for  clotting  state 
would  be  the  ratio  of  minor  chord  length  to  original  droplet  diameter. 
 
An  attempt  to  actuate  the  droplet  as  such  was  unsuccessful. 
 
Used  chip  f7660e8e-1872-43f8-ab23-267de2c4759a  (759a) 
 
 
20181004  wetting  angle  of  propylene  glycol  and  blood  on  DropBot  chip 
 
Took  images  of  DropBot  provided  propylene  glycol  to  measure  wetting  angle.  Four 
droplets  of  3  ul  were  placed  on  the  uncoated  section  of  the  chip  and  four  were  placed  on 
the  coated  section.  Attempted  to  obtain  blood  using  Ergo  Lance  high  flow  needle,  but 
was  unable  to  acquire  enough  blood  to  place  eight  droplets.  One  droplet  of  about  0.4  ul 
was  obtained  and  measured.  Wetting  angle  was  obtained  using  ImageJ  dropsnake 
LBDSA  plugin.  Chip  759a  was  used. 
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Videos  recorded  in  Google  Drive. 
 
 
20181011  wetting  angle  of  blood  on  DropBot  chip 
 
Took  images  of  blood  on  DropBot  chip  759a.  Used  BD  Microtainer  Contact-Activated 
Lancet.  Dispensed  four  droplets  of  ~0.6  ul  on  hydrophobic  surface  of  chip.  Measured 
using  DropSnake  LDBSA  method. 
 
Videos  recorded  in  Google  Drive. 
 
 
20181011  established  protocol  to  create  a  four-electrode  droplet  segment  with  propylene 
glycol 
 
Used  trial-and-error  methods  to  establish  DropBot  protocol.  
 
 
20181015  attempted  to  verify  protocol  and  test  new  chip 
 
Attempted  to  verify  protocol  previously  established.  DropBot’s  onboard  self-tests 
registered  no  shorts  or  channel  errors.  However,  on  chip  759a,  reservoir  electrode  9  failed 
to  actuate.  Other  reservoirs  saw  actuation  but  electrodes  leading  to  the  main  body  of 
electrodes  were  unable  to  see  actuation.  Tested  chip 
186afba5-206d-46c5-b8a6-8c681c68cda8  (cda8).  Reservoir  electrode  9  saw  actuation  as 
normal,  attempted  to  establish  new  protocol.  Observed  that  body  electrodes  beneath  the 
“horizontal”  line  bisecting  the  short  dimension  of  the  chip  did  not  see  actuation. 
 
 
20181029  established  droplet  splitting  protocol  for  four-electrode  segment 
 
Used  propylene  glycol  on  chip  759a.  Established  procedure  starting  from  four-electrode 
segment  to  six-electrode  split.  Tested  at  two  reservoir  pairs,  one  segment  saw  a  complete 
split  and  one  did  not.  Split  at  110  V,  which  was  very  quick  compared  to  100  V  or  95  V. 
 
20181029  attempted  actuation  with  blood 
 
Achieved  actuation  from  reservoir  at  100  V.  Unable  to  actuate  past  two  electrodes  from 
reservoir.  Turned  voltage  up  to  110  V,  and  achieved  actuation  and  droplet  split  per 
previous  protocol.  
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20181102  determined  volume  for  four-electrode  droplet  segment 
 
Used  propylene  glycol  to  experimentally  determine  volume  for  four-electrode  droplet 
segment  on  chip  759a.  The  goal  was  to  dispense  fluid  into  the  reservoir  and  use  this  fluid 
as  the  segment,  rather  than  split  a  portion  of  fluid  from  a  larger  amount  dispensed  in  the 
reservoir.  Verified  DropBot  DB3  120  chip  to  have  electrodes  2.2mm  x  2.2mm  with 
vertical  gap  spacing  (between  plates)  of  180  um.  As  such,  the  volume  of  the 
four-electrode  rounded  rectangle  should  be  slightly  under  3.48  mm 3 . 
 
Attempted  actuation  from  reservoir  85  and  34  at  110V  seeing  difficulty  (perhaps  due  to 
flaking  hydrophobic  coating  at  the  edge  of  the  top  plate).  The  fluid  visibly  spread  along 
the  edge  of  the  top  plate,  past  the  edges  of  the  reservoirs.  Achieved  actuation  with 
reservoir  93  at  120V,  which  was  previously  used  for  blood  actuation,  with  5  ul  dispensed. 
Once  the  droplet  moved  several  electrodes  from  the  reservoir,  actuation  voltage  was 
reduced  to  110V  and  proceeded  as  normal.  Visibly,  the  droplet  was  “caught”  on  the  edge 
of  the  top  plate,  and  a  small  amount  of  fluid  remained  and  broke  off  from  the  main 
volume.  The  volume  of  the  four-electrode  segment  was  thus  determined  experimentally 
to  be  5  ul,  although  it  is  likely  necessary  to  dispense  5.1  or  5.2  ul  to  account  for  fluid  left 
in  the  reservoir. 
 
 
20181108  attempted  to  assess  clotting  of  diluted  fresh  frozen  plasma  (PRP)  using 
thrombin 
 
Collected  vial  of  50ul  of  thrombin  and  vial  of  PRP  from  CP  at  12:40.  Kept  thrombin  on 
ice  and  thawed  PRP.  CP  suggested  thrombin-PRP  ratio  of  1:50  by  volume.  Dispensed  500 
ul  of  PBS,  25  ul  of  PRP  ,  and  0.5  ul  of  thrombin,  mixed  by  pipetting.  Attempted  to  assess 
clotting  with  pipette  tip.  Perhaps  due  to  the  dilution  or  small  tube,  it  was  unclear  if  any 
clotting  occurred.  In  a  second  tube,  dispensed  50  ul  of  PRP  and  ~2  ul  of  thrombin.  Mixed 
with  pipette.  Attempted  to  assess  clotting  with  pipette  tip.  Some  gelling  was  visible,  but 
due  to  the  small  volume  of  fluid,  changes  over  time  were  not  observable. 
 
Thrombin:  https://www.fishersci.com/shop/products/thrombin-restriction-grade/696713 
 
 
20181108  actuation  of  thrombin 
 
Attempted  actuation  of  thrombin  on  chip  759a.  Set  actuation  voltage  to  110V,  dispensed 
~5  ul  of  thrombin  in  reservoir  9.  Fluid  was  not  pulled  under  top  plate,  so  used  pipette  to 
remove  fluid  and  dispensed  in  reservoir  70,  which  successfully  pulled  the  fluid  under  the 
top  plate.  Attempted  to  actuate  the  thrombin  across  the  chip  towards  reservoir  49. 
Successfully  pulled  a  three-electrode  segment  of  fluid  upon  increasing  voltage  to  130V. 
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Thrombin:  https://www.fishersci.com/shop/products/thrombin-restriction-grade/696713 
25  U/ml. 
Videos  recorded  in  Google  Drive. 
 
 
20181113  off-chip  clotting  testing  with  plasma  and  thrombin 
 
 
Acquired  PRP  and  thrombin  from  CP  at  11:30  am.  Immediately  placed  both  in  freezer 
section  of   E115  refrigerator.  Took  PRP  out  at  1:10  pm  to  thaw.  Diluted  100  ul  of  PRP 
1:10  with  PBS  in  one  tube  and  placed  100  ul  of  PRP  in  another.  Added  2  ul  of  thrombin 
to  each  tube  and  mixed  by  pipetting  several  times.  The  pure  PRP-thrombin  visibly 
retained  air  bubbles  upon  mixing. 
 
Attempted  to  test  gel  action  by  placing  droplets  on  glass  slides,  then  holding  the  slide  at 
an  angle  to  observe  the  droplet’s  motion  on  the  slide.  Droplets  from  diluted  PRP  and  pure 
PRP  were  indistinguishable  by  sight.  Both  flowed  down  the  glass  slide  freely,  with  a  very 
small  wetting  angle. 
 
Combined  200  ul  of  PRP  with  5  ul  of  thrombin  and  mixed  by  pipetting.  Mixture  appeared 
to  gel  by  sticking  on  the  pipette  tip.  A  droplet  from  this  sample  was  placed  on  a  glass 
slide,  and  the  motion  upon  tilting  was  indistinguishable  from  either  other  sample,  flowing 
freely  down  the  slide  and  showing  no  evidence  of  gelling. 
 
A  possible  cause  for  this  is  the  hydrophilicity  of  PRP  on  the  glass  slide.  
 
 
20181126  off-chip  clotting  testing  with  plasma  and  thrombin 
 
Obtained  platelet-rich  plasma  (PRP)  frozen,  CaC2  (diluted  in  what?),  and  thrombin  from 
CP  at  12:00  pm.  In  four-contained  clot  tray,  mixed  four  samples.  Each  sample  contained 
100  ul  of  PRP,  2  ul  of  CaC2,  and  2  ul  of  thrombin.  Samples  had  0  ul,  50  ul,  100  ul,  and 
200  ul  of  DI  water  to  dilute  the  PRP.  Samples  were  made  by  dispensing  the  DI  water  into 
each  tray,  then  dispensing  the  PRP  into  each  tray.  CaC2,  then  thrombin  was  then 
dispensed  into  each  tray.  Mixing  was  done  by  pipette,  taking  the  sample  into  the  pipette 
and  re-dispensing.  The  rapid  clotting  time  presented  a  mixing  challenge,  as  only  one 
sample  could  be  mixed  at  a  time.  As  such,  the  50  ul  and  100  ul-diluted  samples  were 
noticeably  less  homogenous  than  the  0  ul  and  200  ul  samples.  The  mixing  time  was  also 
extended  so  as  to  not  introduce  air  bubbles  into  the  samples.  
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After  ~1  minute,  gelling  was  apparent  by  sight  in  the  undiluted  sample.  After  ~5  minutes, 
gelling  was  apparent  in  all  samples,  including  the  sample  diluted  by  200  ul  of  water. 
After  ~15  minutes,  samples  were  prodded  using  a  stirrer.  Especially  in  the  100  ul  and  200 
ul-diluted  samples,  it  appeared  that  the  clots  formed  were  very  non-homogeneous, 
forming  a  gel  mass  with  surrounding  liquid.  After  ~20  minutes,  a  visibly  opaque  white 
mass  ~6  mm  in  diameter  was  observed  in  the  50  ul  sample.  
 
 
20181203  off-chip  clotting  testing  with  plasma  and  thrombin 
 
PRP  obtained  from  CP  at  12:35.  Used  100  ul  of  plasma  in  each  sample.  Dispensed  water, 
then  plasma  and  mixed  by  pipette.  Dispensed  2  ul  of  calcium,  then  2  ul  of  thrombin. 
Mixed  by  pipette.  Using  pipette  tip,  no  clotting  action  was  visible.  To  verify  materials, 
dispensed  200  ul  of  plasma,  5  ul  of  calcium,  and  5  ul  of  thrombin  and  mixed  by  pipette. 
Clotting  was  observed.  Waited  5  minutes  and  placed  specimens  on  angled  glass  slide  to 
observe  wetting  action.  No  differences  between  samples  were  observed.  
 
 
Specimen  No.  Dilution Water  vol. 
1 1:5 .5  ml 
2 1:8 .8  ml 
3 1:12 1.2  ml 
4 1:15 1.5  ml 
 
 
2019114  on  chip  specimen  creation  and  mixing  protocol 
 
Chip  c4c5.  Mixed  5  ul  FFP  with  10  ul  PBS,  and  in  a  separate  container,  2  ul  Ca02  and  2 
ul  thrombin.  Did  not  add  surfactant.  Did  not  successfully  actuate  on  chip  as  the  FFP-PBS 
mixture  would  not  suck  under  the  top  plate.  Tested  reservoir  9  vertical  pair  with  provided 
propylene  glycol  sample  fluid  and  achieved  actuation  from  the  lower  reservoir  to 
reservoir  9. 
 
At  this  time,  the  thrombin  and  plasma  were  too  old  (~1  hr)  to  continue  clotting  so 
attempted  to  determine  on-chip  plasma  actuation  dilution.  Created  specimens  at  1:4,  1:5, 
1:8,  and  1:10  dilution  (all  with  20  ul  of  FFP).  Added  ~0.5  ul  of  surfactant,  but  amounts 
are  imprecise  due  to  surfactant  viscosity.  Achieved  actuation  with  100  V  of  1:4  dilution, 
but  later  required  120  V  to  actuate  and  the  specimen  gradually  slowed  in  actuatability 
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(perhaps  dried  out?).  Achieved  actuation  of  1:5  dilution  with  120  V,  the  specimen 
gradually  slowed  in  actuatability,  switched  to  130  V,  the  specimen  was  eventually  not 
actuatable  with  130  V.  
 
Video  of  FFP  1:5  actuation  recorded  in  Google  Drive. 
Video  of  FFP  1:4  actuation  recorded  in  Google  Drive.  Surfactant  is  Tetronic  90R. 
 
 
20190117  on-chip  FFP  pull  tests 
 
Chip  c4c5.  Created  four  FFP  specimen  concentrations  at  1:8  (20  ul  FFP,  160  ul  PBS), 
1:12  (20  ul  FFP,  240  ul  PBS),  1:16  (20  ul  FFP,  320  ul  PBS),  1:20  (20  ul  FFP,  400  ul 
PBS).  Attempted  to  add  0.1%  by  volume  surfactant  to  each  specimen,  but  the  viscosity  of 
the  surfactant  means  the  additions  were  very  imprecise.  Mixed  using  vortex  mixer  for  15 
s  at  3000  rpm.  Unable  to  pull  FFP.  Began  at  80  V  and  increased  to  120  V.  Actuation 
became  difficult  as  time  went  on  and  eventually  specimens  stopped  moving.  Became 
visually  cloudy 
 
 
20190130  on-chip  Whole  blood  pull  tests 
 
Chip  c4c5.  Created  blood  specimen  with  40  ul  whole  blood,  800  ul  PBS,  ~1  ul  Tetronic 
90R4.  Mixed  by  pipette,  completed  ~30  pumps  at  150  ul.  Actuated  on  reservoir  26  at  80 
V.  Specimen  was  easily  sucked  under  top  plate  and  actuated,  albeit  slowly,  at  80V. 
Specimen  was  ~5  electrodes  so  a  pull  test  over  an  additional  electrodes  was  conducted. 
Unable  to  pull  specimen  at  80  V,  so  went  up  to  90  V.  Still  unable  to  pull,  so  went  to  100 
V.  Specimen  pulled  to  characteristic  “hourglass”  shape,  but  visibly  separated.  Pull  was 
much  slower  than  that  of  PBS  or  previous  whole  blood  at  120  V.  Previous  whole  blood 
specimen,  also  diluted  1:20,  was  mixed  with  vortexer.  After  returning  blood  to  reservoir 
26,  could  not  extract  with  pipette,  cleaned  by  wicking. 
 
Created  blood  specimen  with  80  ul  whole  blood,  800  ul  PBS<  ~1  ul  Tetronic  90R4. 
Mixed  by  pipette,  completed,  ~30  pumps  at  180  ul.  Actuated  on  reservoir  93.  Pulled 
whole  specimen  over  four  segments  at  80  V.  Went  to  90  V  at  5:25.  Pull  tested  at  100  V. 
Went  to  110  V  at  9:05.  Blood  noticeably  separated.  At  19:10  went  to  90  V,  at  19:41  went 
to  120  V,  20:31,  went  to  80  V.  Unable  to  return  specimen  to  reservoir,  so  removed  by 
wicking. 
 
1:20  Videos  recorded  in  Google  Drive. 
 




20190201  on-chip  Whole  blood  pull  tests 
 
Attempted  to  actuate  whole  blood  undiluted.  Used  whole  blood  which  was  ~54  hours  old. 
Combined  ~160  ul  whole  blood  with  ~1  ul  surfactant,  mixed  by  pipette.  During  mixing 
blood  and  surfactant,  a  gel  substance  was  noticeable,  potentially  made  of  the  surfactant 
(very  viscous)  combined  with  the  blood.  Attempted  several  times  on  reservoirs  93,  26, 
and  the  both  of  the  pair  to  the  left.  Voltages  ranged  from  80  V  to  120  V.  Blood  would 
easily  slip  under  top  plate,  and  would  sometimes  actuate  to  first  electrode,  but  would  stop 
at  second  electrode  and  eventually  stopped  responding  to  actuation.  This  may  be  because 
the  surfactant  gels  when  mixed  with  the  blood,  causing  the  blood  to  not  reduce  in  surface 
tension. 
 
Videos  recorded  in  Google  Drive. 
 
20190206  on-chip  Whole  blood  pull  tests 
 
Chip  c4c5.  Suspected  short  at  electrode  82,  66,  21,  reserv.  70,  34.  Tested  with  propylene 
glycol  and  verified  no  actuation  on  82,  66,  38,  reserv.  34.  Switched  to  chip  cda8. 
 
Suspected  on  cda8:  67,  83,99,110,114.  With  propylene  glycol,  verified  no  actuation  on 
67,  83,  99,  110,  114.  Inserted  test  chip  and  ran  all  onboard  tests,  which  verified  no  shorts 
and  no  open  circuits. 
 
Inserted  chip  4540.  Restarted  MicroDrop.  Attempted  actuation  with  sample  fluid. 
Verified  actuation  on  49-70  (rightmost)  reservoir  pair.  Restarted  MicroDrop  and  inserted 
chip  c4c5.  Attempted  actuation  on  reservoir  9  to  electrode  10  and  reservoir  26  to 
electrode  20  with  no  response.  Reservoir  34  did  not  show  response,  but  electrode  36 
actuated  the  sample  fluid.  Electrode  37  showed  no  response. 
 
Quit  MicroDrop  software.  Inserted  chip  4540.  Attempted  actuation  with  sample  fluid. 
Achieved  actuation. 
 
 
20190212  on-chip  Whole  blood  pull  tests 
 
Used  chip  4540.  Created  whole  blood  specimens  with  1  ml  PBS,  20  ul  whole  blood,  0.1% 
surfactant  Tetronic  90R4.  Attempted  actuation 
 
Inserted  chip  cda8.  Attempted  actuation  from  reservoir  110  at  100  V.  Verified  actuation.  
Actuated  whole  blood  from  reservoir  110  at  100  V.  Saw  rapid  actuation  into  test  zone, 
performed  pull  test  successfully. 
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Actuated  whole  blood  from  reservoir  93.  Also  saw  rapid  actuation,  ran  test.  Had  forgotten 
to  start  video,  so  quit  test,  started  video,  and  performed  test  again.  The  specimen 
deformed  noticeably  more  slowly  than  the  first  unrecorded  test.  Specimen  saw  slow 
actuation  back  to  reservoir.  
Attempted  actuation  from  reservoir  85.  Actuated  specimen  to  position  and  performed  pull 
test.  Was  noticeably  slower  than  prior  two  pull  tests.  Unable  to  return  specimen  to 
reservoir.  Had  to  wick  specimen  out  of  chip. 
Attempted  actuation  from  reservoir  70.  Quickly  actuated  specimen  to  test  zone.  Initiated 
pull  test,  which  was  noticeably  slower  than  the  prior  3  tests.  Unable  to  return  specimen  to 
reservoir,  had  to  wick. 
Again  attempted  actuation  on  reservoir  110.  Successfully  pulled  specimen  into  zone  at 
105  V.  Attempted  test,  but  specimen  appeared  immobile.  Actuated  back  to  reservoir  at 
120  V. 
Made  sure  to  regularly  mix  specimens  by  pipette. 
 
 
20190214  on-chip  PG  pull  tests 
 
Chip  cda8. 
 
PG_2R1_021419cda8.mpg  pull  at  00:17.  Pulls  on  propylene  glycol  were  inconsistent  and 
challenging,  suggesting  biofouling  and  residue  playing  a  significant  role  in  actuation 
difficulty.  Will  wait  for  new  chips  and  achieve  data  from  propylene  glycol. 
 
 
20190219  on-chip  PG  pull  tests  for  repeatability  and  reproducibility 
 
Chip  4dda.  Attempted  pulls  on  propylene  glycol  at  100  V.  Dispensed  5.5  ul  of  PG  in  all 
reservoirs.  Could  not  purge  air  from  pipette  so  inconsistent  dispensed  volume.  Added  ~1 
ul  to  middle  two  specimens.  Actuated  all  specimens  into  pull  test  position  at  90  V.  Pulled 
specimens  simultaneously  at  100  V.  Returned  to  position  at  90  V  for  ~1  min  30  s  and 
repeated  pull  three  times.  Residue  (?)  was  visible  on  sides  of  specimens. 
 
Returned  specimens  to  original  reservoirs.  Manipulated  droplets  to  clean  off  residue. 
Moved  specimens  to  upper  reservoirs,  rather  than  lower.  Some  specimens  actuated  to  test 
position  quicker  (as  before),  but  made  sure  to  turn  off  electrodes  for  resting  specimens  so 
as  to  avoid  residue  formation.  Briefly  increased  voltage  to  110  V  in  order  to  pull 
specimen  1  from  reservoir.  Held  specimens  in  positions  at  100  V  for  ~30  s  then  pulled  at 
100  V.  Repeated  pull  three  times  as  previous.  All  specimens  (except  position  2)  necked 




Pull  1:  07:55 
Neutral  1:  17:55 
Pull  2:  19:30 
Neutral  2:  26:40 
Pull  3:  28:30 
N3:  36:22 
 
(VOID)  PGR2_4dda_021919.mp4 
Pull  1:  1:00 
N1:  6:40 
P2:  7:40 
N2:  12:48 
P3:  13:48 
N3:  18:48 
 
 
20190220  on-chip  PG  pull  tests  for  repeatability  and  reproducibility 
 
Used  chip  4dda.  Dispensed  5.75  ul  of  propylene  glycol  (PG)  into  all  four  “bottom-side” 
reservoirs.  Actuated  at  100  V.  Used  110  V  briefly  to  pull  specimen  from  reservoir  in  lane 
4.  Tried  to  “wipe  down”  residue  from  PG  at  sites  using  on-chip  PG  specimens.  Brought 
specimens  back  to  reservoirs  and  removed  by  pipette. 
 
PGR3_4dda_022019.mp4 
P1  -  2:10 
P2  -  9:10 
P3  -  15:30 
 
Dispensed  5.75  ul  of  fluid  into  each  reservoir.  Actuated  into  position  at  110  V.  Pulled 
specimens  at  110  V.  Made  two  mistakes:  the  specimen  at  lane  4  split  and  it  was  not 
reassembled  between  pulls  1  and  2,  and  two  replicates  were  completed  rather  than  three. 
Returned  specimens  to  reservoir,  wiping  down  residue  and  removing  specimens  by 
pipette.  Dispensed  5.75  ul  of  new  sample  fluid.  Completed  three  replicates,  pulling  at  110 
V.  Removed  specimens  as  described  above.  Dispensed  5.75  ul  of  new  sample  fluid, 
completed  an  additional  three  replicates  pulling  at  110  V  and  removing  specimens  as 
described  above.  
 
PG110VR1_4dda_022019.mp4 
P1  -  3:00 
P2  -  9:50 




P1  -  3:52 
P2  -  10:00 
P3  -  16:00 
 
 
20190305  on-chip  thrombin  actuation  attempt 
 
Used  chip  4540.  Obtained  ~20  ul  thrombin  from  E203.  Added  in  ~0.1%  Tetronic  90R4 
and  mixed  by  vortex.  Volume  of  added  Tetronic  90R4  is  approximate  due  to  high 
viscosity.  Attempted  actuation  on  leftmost  bottom  reservoir.  Dispensed  ~5  ul  and 
attempted  actuation.  Thrombin  specimen  got  “stuck”  so  added  ~4  ul  of  thrombin 
specimen.  Varied  voltage  from  100V  -  120V,  achieved  some  actuation.  “Unstuck” 
thrombin  from  top  plate  edge  at  reservoir,  but  specimen  remained  stuck  within  first 
electrode  in  grid.  Pulled  specimen  successfully  back  to  reservoir.  Chip  4540  has  seen 
fouling  so  this  may  be  the  cause. 
 
Actuation  video  record  THR_030529.mp4  in  Google  Drive. 
 
 
20190308  on-chip  thrombin  actuation  attempt 
 
Initiator  was  50  ul  calcium,  8  ul  thrombin,  ~0.1%  Tetronic  90R4  surfactant.  Blood  was 
1.5  ml  whole  blood  +  0.1%  surfactant. 
 
Chip  4540  100-100V,  2000-10000  Hz.  Thrombin  quickly  clouded  over  visually,  “froze” 
at  initial  electrodes  after  a  couple  minutes. 
Chip  4dda,  dispensed  ~5  ul  of  thrombin+calcium  initiator  mixture.  Actuated  initiator  at 
5000  Hz  80  V  from  reservoir  (top  row,  second  from  left).  Moved  initiator  into  lane, 
centered  between  reservoirs.  
Went  up  to  100  V  at  6:27.  Dispensed  ~6  ul  blood  into  reservoir  93(?).  Moved  initiator 
adjacent  to  blood.  Initiator  and  blood  droplet  specimens  were  initially  adjacent  but  not 
merged.  After  a  minute  or  so,  the  droplets  merged.  Turned  off  all  electrodes  at  7:58. 
Waited  ~20  min  for  clot  to  develop.  
 
Attempted  to  actuate  excess  initiator  away  from  blood  but  unsuccessful.  Initiator  appears 
“stuck”  on  a  particle  or  “gel  line.”  This  could  be  surfactant?  Attempted  to  remove  blood 
by  pipette  using  PBS  to  break  surface  tension.  Blood  appeared  fully  clotted,  or  perhaps 
dried.  Attempted  to  wick  blood  out.  The  blood  at  the  top-bottom  plate  reservoir  entrance 
acted  as  a  solid  barrier  for  wicking  Kimwipes.  Video  is  CLOT_030819.mp4  but  has 




20190327  on-chip  PBS  pulls  (with  fluorescein) 
 
Chip  82949ADC-28A6-11E9-BDCE-9CB6D0E73EB4.  Placed  such  that  text  “SCI-BOTS 
90-pin  array  v3”  was  not  placed  against  back  of  DropBot.  Added  500  ul  of  PBS,  added 
0.0262  g  of  Tetronic  90R4  on  scale.  Added  an  additional  1000  ul  of  PBS  and  75  ul  of 
fluorescein.  Conducted  tests  with  homemade  “darkbox”  over  camera.  Dispensed  5.5  ul  of 
specimen  into  each  “bottom”  reservoir  and  actuated  all  specimens  into  position  by  hand. 
Pulled  specimens  simultaneously  at  at  100  V  using  protocol  “Pull  test  100  V”. 
 
Video  recorded  in  Google  Drive. 
 
 
20190328  on-chip  PBS  pulls  (with  fluorescein) 
 
Chip  82949ACF-25A5-11E9-B21B-9CB6D0E37EB4.  Dispensed  PBS  specimen  created 
on  03-27-19.  Dispensed  5.5  ul  of  specimen  on  each  bottom  reservoir  on  chip.  Put  “dark 
box”  over  DropBot.  Actuated  all  specimens  into  test  sites.  Pulled  all  specimens  at  100  V. 
Tests  were  noticeably  slower  than  the  previous  tests,  with  only  two  specimens  fully 
splitting.  Rightmost  specimen  was  noticeably  larger  in  area  than  other  specimens. 
 
Video  recorded  in  Google  Drive. 
 
 
20190507  on-chip  RBC  pulls  to  verify  hematocrit  % 
 
Chip  82949ACF-28A6-11E9-B218-9CB6D0E37EB4 
 
 
For  H=2.5%,  1.462  ml  PBS,  38  ul  blood.  
For  H=5%,  1.425  ml  PBS,  75  ul  blood. 
H=10%,  1.350  ml  PBS,  150  ul  blood. 
All  specimens  were  mixed  by  pipette  at  between  10  and  20  times.  H=2.5%  was  tested 
first,  actuated  at  100  V  and  saw  a  strong  response  and  successful  pull  test.  H=5%  was 
tested  next,  actuated  at  100  V  and  saw  a  strong  response  and  successful  pull  test.  H=10% 
was  tested  last,  actuated  100  V,  was  slightly  slower  to  leave  the  reservoir,  but  saw  a 
successful  pull  test. 
 
Video  recorded  in  Google  Drive. 
 
 
20190510  on-chip  RBC  pulls 
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One  donor  used.  Created  samples  at  10%  hematocrit.  Centrifuged  whole  blood  at  250  rcf, 
acc  7,  break  0,  time  20  min,  (collected  ~1  hour  before),  pulled  and  disposed  plasma  and 
WBC  layer  with  pipette.  Added  500  ul  RBCs  and  4500  ul  PBS  to  a  tube  and  centrifuged 
at  same  settings  to  wash.  Removed  and  disposed  of  PBS  by  pipette. 
 
Created  samples  at  10%  hematocrit  by  dispensing  900  ul  PBS  and  0.2%  (of  1  ml  ) 
surfactant  into  a  microcentrifuge  tube.  Mixed  using  a  vortex  mixer  at  3000  rpm  for  15  s. 
Dispensed  100  ul  of  washed  RBC 
 
Inserted  chip  1  (EC484FB9-03C5-11E9-816F-9CB6D0E37EB4)  in  “up”  orientation 
(“SCI-BOTS”  patterned  text  on  glass  is  towards  the  back  of  the  DropBot).  Chip  2  is 
EC484FC2-03C5-11E9-835D-9CB6D0E37EB4. 
 
C1L1  Pull  at  0:58 
C1L3  Pull  at  0:50 
 
 
20190514  on-chip  RBC  pulls 
 
Chip  4,  electrode  18  not  addressable 
Chip  3  -  EC4B28C8-03C5-11E9-93B8-9CB6O0E37EB4 
 
 
20190607  On-chip  pulls 
 
Weighed  0.035  g  of  surfactant,  added  15.2  ml  of  PBS  to  achieve  0.2%  by  volume  (for 
90%  PBS,  10%  RBCs).  Mixed  by  vortex. 
 
C3L2  -  Electrodes  26,  21,  98  not  actuating. 
 
Chip  7 Untreated Untreated Treated Treated 
Chip  8 Treated Treated Untreated Untreated 
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